Private placement: Positive factors in the stock market are accumulating. Recently, A-shares have fluctuated, and the latest strategies of many first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. (CSI)Sinotrans has set up a new company, including land international cargo transportation agency business. The enterprise search APP shows that recently, Sinotrans Logistics (Alashankou) Co., Ltd. was established with Chen Xin as its legal representative and registered capital of 10 million yuan. Its business scope includes: domestic container cargo transportation agency; International freight forwarder; Land international freight forwarding agent; Import and export agents, etc. Enterprise survey shows that the company is indirectly wholly-owned by Sinotrans.Sony Group's share price hit a record high in intraday trading, and Sony Group's share price broke through the high of 3,390 yen set in 2000, reaching a record high.
Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.According to the monetary authority of singapore survey, economists predict that the core inflation rate will be 1.8% in 2025.Volvo Cars: The Daqing plant has rolled off 500,000 vehicles.
Local regulators have found out the situation of institutions purchasing unlicensed financial information service products. The reporter was informed that some local securities regulatory bureaus are finding out the situation of institutions purchasing unlicensed financial information service products. The regulatory requirements require the securities fund and futures-related operating institutions within their jurisdiction to self-inspect the purchase of foreign financial information service products without the permission of the National Network Information Office. The main contents include a brief description of financial information service products, the contact telephone number and email address of foreign institutions, and so on. According to relevant regulations, the provision of financial information services by foreign institutions in China must be approved. Up to now, a total of 31 foreign institutions and 10 enterprises invested and established by foreign institutions in China have been licensed to provide financial information services. (Cailian) Yanshan Technology has set up a new subsidiary in Shanghai. According to the enterprise search APP, Shanghai Yunsong Technology Co., Ltd. was recently established with Zhang Weiming as the legal representative and a registered capital of 10 million yuan. Its business scope includes technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion. Enterprise equity penetration shows that the company is wholly owned by Yanshan Technology.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14